Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption

Md Ismail Ahamed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman

PDF(639 KB)
PDF(639 KB)
Intelligent Pharmacy ›› 2024, Vol. 2 ›› Issue (3) : 308-311. DOI: 10.1016/j.ipha.2024.02.003
Short communication

Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption

Author information +
History +

Abstract

Artificial intelligence (AI) has immense potential to revolutionize pharmacy operations by simplifying procedures, improving efficiency, and expediting pharmaceutical research. Nevertheless, obstacles such as steep expenses, absence of faith in AI, worries about unemployment, threats to privacy, and the incapacity to substitute human decision-making have impeded acceptance. This text discusses the future of AI in the field of pharmacy, obstacles that are preventing its usage, and methods to make its integration easier. The expansion of large data in healthcare offers chances for AI to obtain understanding, but examining and implementing information still presents difficulties. Significant obstacles such as costly implementation, safety concerns, restrictions on data exchange by regulations, and absence of interpersonal interaction need to be resolved. Methods to facilitate acceptance involve upgrading medical instruction to center around AI, involving interested parties, allocating resources for research and development, creating safeguarded machine learning methods, and carefully incorporating AI to enhance, rather than replace, pharmacy personnel. Although additional effort is required to establish confidence in AI and address genuine worries, specific actions can tap into AI's capacity to enhance effectiveness, lower expenses, expedite drug exploration, and improve healthcare for patients. Responsible and moral adoption requires tackling obstacles through cooperation among interested parties and gradual incorporation centered on enhancing human workforce, rather than substituting them.

Keywords

Artificial intelligence / Pharmacy / Clinical pharmacy / Pharmacy management

Cite this article

Download citation ▾
Md Ismail Ahamed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman. Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption. Intelligent Pharmacy, 2024, 2(3): 308‒311 https://doi.org/10.1016/j.ipha.2024.02.003

References

[1]
Jarab AS, Abu Heshmeh SR, Al Meslamani AZ. Artificial intelligence (AI) in pharmacy: an overview of innovations. J Med Econ. 2023;26(1):1261–1265.
CrossRef Google scholar
[2]
Oparah AC, Trop EA-O. Evaluation of community pharmacists’ involvement in primary health care. Trop J Pharmaceut Res. 2002;1(2):67–74.
CrossRef Google scholar
[3]
Karajgikar Dr MK. Critical study on application of AI in pharmaceutical management for digitalization of business process. J Res Adm. 2023;5(2):10297–10307 [Online]. Available: https://journalra.org/index.php/jra/article/view/1103. Accessed January 6, 2024.
[4]
Dash S, Shakyawar SK, Sharma M, Kaushik S. Big Data in Healthcare: Management, Analysis and Future Prospects. J Big Data [Internet];2019. Dec 1[cited 2024 Jan 6];6(1):1–25. Available from: https://journalofbigdata.springeropen.com/articles/10.1186/S40537-019-0217-0.
[5]
Li T, Xiao Z, Georges HM, Luo Z, Wang D. Performance analysis of co-and cross-tier device-to-device communication underlaying macro-small cell wireless networks. KSII Transactions on Internet and Information Systems. 2016 Apr 30;10(4):1481–1500.
CrossRef Google scholar
[6]
Yang YC, Islam SU, Noor A, Khan S, Afsar W, Nazir S. Influential usage of big data and artificial intelligence in healthcare. Comput Math Methods Med. 2021:2021.
CrossRef Google scholar
[7]
Rallapalli S, Gondkar RR, Ketavarapu UPK. Impact of processing and analyzing healthcare big data on cloud computing environment by implementing hadoop cluster. Procedia Comput Sci. 2016 Jan 1;85:16–22.
CrossRef Google scholar
[8]
Jarab AS, Abu Heshmeh SR, Al Meslamani AZ. Artificial intelligence (AI) in pharmacy: an overview of innovations. J Med Econ. 2023;26(1):1261–1265.
CrossRef Google scholar
[9]
Vyas M, Thakur S, Riyaz B, Bansal KK, Tomar B, Mishra V. Artificial intelligence: the beginning of a new era in pharmacy profession. Asian J Pharm. 2018;12(2):72.
CrossRef Google scholar
[10]
Bartoletti I. AI in healthcare: ethical and privacy challenges. Lect Notes Comput Sci. 2019;11526:7–10.
CrossRef Google scholar
[11]
Ghassemi M, Oakden-Rayner L, Beam AL. The false hope of current approaches to explainable artificial intelligence in health care. Lancet Digit Health. Nov. 2021;3(11): e745–e750.
CrossRef Google scholar
[12]
PDF) PRIVACY PREVENTION OF HEALTH CARE DATA USING AI [Internet]. [cited 2024 Jan 7]. Available from: https://www.researchgate.net/publication/375957548_PRIVACY_PREVENTION_OF_HEALTH_CARE_DATA_USING_AI.
[13]
Hlávka JP. Security, privacy, and information-sharin. aspects of healthcare artificial intelligence. Artificial Intelligence in Healthcare. 2020 Jan 1:235–270.
CrossRef Google scholar
[14]
Davahli MR, Karwowski W, Fiok K, Wan T, Parsaei HR. Controlling safety of artificial intelligence-based systems in healthcare. Symmetry. 2021;13. Page 102 [Internet]. 2021 Jan 8 [cited 2024 Jan 8];13(1):102. Available from: https://www.mdpi.com/2073-8994/13/1/102/htm.
[15]
Santhosh A, Unnikrishnan D, Shibu S, Meenakshi KM, Joseph G. AI IMPACT ON JOB AUTOMATION. International Journal of Engineering Technology and Management Sciences [Internet];2023 [cited 2024 Jan 8];7(4):410–25. Available from: https://ijetms.in/Vol-7-issue-4/Vol-7-Issue-4-55.html.
CrossRef Google scholar
[16]
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems | FDA [Internet]. [cited 2024 Jan 8]. Available from: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-art ificial-intelligence-based-device-detect-certain-diabetes-related-eye.
[17]
khan B, Fatima H, Qureshi A, Kumar S, Hanan A, Hussain J, et al. Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector. Biomedical Materials & Devices [Internet]. 2023 Sep 8 [cited 2024 Jan 8];1(2):731–8. Available from: https://link.springer.com/article/10.1007/S44174-023-00063-2.
CrossRef Google scholar
[18]
Väänänen A, Haataja K, Vehviläinen-Julkunen K, Toivanen P. AI in healthcare: a narrative review. F1000Research. 2021;10:6. 2021 10:6.
CrossRef Google scholar
[19]
Senbekov M, Saliev T, Bukeyeva Z, et al. The recent progress and applications of digital technologies in healthcare: a review. Int J Telemed Appl. 2020:2020.
CrossRef Google scholar
[20]
Naik N, et al. Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility? Front Surg. 2022;9:862322. https://doi.org/10.3389/FSURG.2022.862322.
[21]
Wang C, Liu S, Yang H, Guo J, Wu Y, Liu J. Ethical considerations of using ChatGPT in health care. J Med Internet Res. 2023;25(1):e48009.
CrossRef Google scholar
[22]
Paranjape K, Schinkel M, Nannan Panday R, Car J, Nanayakkara P. Introducing Artificial Intelligence Training in Medical Education. JMIR Med Educ [Internet];2019. Dec 3[cited 2024 Jan 17];5(2):e16048. Available from: http://www.ncbi.nlm.nih. gov/pubmed/31793895.
CrossRef Google scholar
[23]
Petersson L, et al. Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in Sweden. BMC Health Serv Res. 2022;22(1):1–16.
CrossRef Google scholar
[24]
Makne PD, Sontakke SS, Lakade RD, Tompe AS, Patil SS. ARTIFICIAL INTELLIGENCE: A REVIEW. World Journal of Pharmaceutical Research www.wjpr.net │ [Internet]. 2015 [cited 2024 Jan 18];12:739. Available from: www .wjpr.net.
[25]
Renukappa S, Mudiyi P, Suresh S, Abdalla W, Subbarao C. Evaluation of challenges for adoption of smart healthcare strategies. Smart Health. 2022 Dec 1;26:100330.
CrossRef Google scholar
[26]
He J, Baxter SL, Xu J, Xu J, Zhou X, Zhang K. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019;25(1):30–36.
CrossRef Google scholar
[27]
Murdoch B. Privacy and artificial intelligence: challenges for protecting health information in a new era. BMC Med Ethics. 2021;22(1):1–5.
CrossRef Google scholar
[28]
Butpheng C, Yeh KH, Xiong H. Security and privacy in IoT-cloud-based e-health systems—a comprehensive review. Symmetry. 2020;12:1191 [Internet]. 2020 Jul 17 [cited 2024 Jan 20];12(7):1191. Available from: https://www.mdpi.com/2073 -8994/12/7/1191/htm.
[29]
Ali H, Javed RT, Qayyum A, Alghadhban A, Alazmi M, Alzamil A, et al. SPAM-DaS: Secure and Privacy-Aware Misinformation Detection as a Service. Authorea Preprints [Internet]. 2023 Oct 31 [cited 2024 Jan 20];Available from: https://www.authorea.com/doi/full/10.36227/techrxiv.19351679.v2?commit=eabf536f5e93d39ed2C71 00e92158C40f90d4de8.
[30]
Al-Rubaie M, Chang JM. Privacy-preserving machine learning: threats and solutions. IEEE Secur Priv. 2019 Mar 1;17(2):49–58.
CrossRef Google scholar
[31]
Khalid N, Qayyum A, Bilal M, Al-Fuqaha A, Qadir J. Privacy-preserving artificial intelligence in healthcare: techniques and applications. Comput Biol Med. 2023 May 1;158:106848.
CrossRef Google scholar
[32]
Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intelligent Pharmacy. 2023 Jun 1;1(1):32–40.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
AI Summary AI Mindmap
PDF(639 KB)

Accesses

Citations

Detail

Sections
Recommended

/